| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $253K | -62.4% |
| SG&A Expense | $562K | -14.8% |
| Operating Income | -$815K | +38.9% |
| Net Income | -$324K | +82.1% |
| EPS (Basic) | -$0.08 | +77.8% |
| EPS (Diluted) | -$0.08 | +77.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176K | -78.3% |
| Current Assets | $1.1M | +26.2% |
| Total Assets | $1.4M | +22.4% |
| Total Liabilities | $3.1M | -15.8% |
| Stockholders' Equity | -$2.3M | +19.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$932K | +5.5% |
| Capital Expenditures | $79K | -61.7% |
| Investing Cash Flow | -$721K | -275.5% |
| Financing Cash Flow | $1.0M | -9.2% |
| Free Cash Flow | -$1.0M | +15.2% |